NL-OMON36661撤回不适用
I-131 remnant ablation in differentiated thyroid cancer-optimal treatment with maximal outcome - rhTSH stimulated remnant ablation in differentiated thyroid cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 入组人数
- 144
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •low and high risk patients (AJCC 6) with recently diagnosed histological proven differentiated thyroid cancer, who have to be treated with ablation therapy
- •aged 18 years or older
- •not pregnant
- •not major concurrent diseases (such as stable cardiovascular disease, concurrent malignancy treated < 5 years) leading to a reduced survival < 1 year
- •normal renal function
排除标准
- •Stage M1 when known before ablation
研究者
相似试验
招募中
不适用
Ablation therapy in differentiated thyroid cancer with recombinant TSH.gedifferentieerd schildkliercarcinoomdifferentiated thyroid cancerablation therapyablatie therapierecombinant TSH thyroid hormone withdrawalschildklierhormoon onttrekkingI-131 therapieNL-OMON23578Prof.dr. T.P. Links, endocrinologist144
进行中（未招募）
不适用
Radioiodine ablation of post-surgical thyroid remnants by recombinant human TSH (rhTSH) in patients with moderately severe and severe Graves' orbithopathy (GO) - Graves' orbithopathy and rhTSHPatients affected with moderately severe and severe GOMedDRA version: 14.1Level: SOCClassification code 10015919Term: Eye disordersSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: HLGTClassification code 10043739Term: Thyroid gland disordersSystem Organ Class: 10014698 - Endocrine disordersEUCTR2010-020855-29-ITIVERSITA' DEGLI STUDI DI MESSINA
撤回
不适用
Fast-track thyroidectomy and I-131 radioiodine ablation therapy in patients with differentiated thyroid cancer.1004373910014713Thyroid cancerNL-OMON38352niversitair Medisch Centrum Utrecht70
已完成
不适用
Fast-track thyroidectomy and radioiodine ablation therapy in patients with differentiated thyroid cancer.Differentiated thyroid cancer1004373910014713NL-OMON39885niversitair Medisch Centrum Utrecht58
已完成
不适用
A Retrospective Observational Study Comparing Two Different Treatment Options in Thyroid Cancer Patients With T4 TumoursThyroid CancerNCT01736163Genzyme, a Sanofi Company144